Multicenter Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease.
Rishika ChughManuel B Braga NetoThomas W FredrickGuilherme P RamosJonathan TerdimanNajwa El-NachefEdward V LoftusUma MahadevanSunanda V KanePublished in: Journal of Crohn's & colitis (2022)
In this real-world cohort of highly refractory Crohn's disease patients, upadacitinib was effective in inducing remission and had an acceptable safety profile.